Sun Pharmaceutical Industries Inc recalls Lisdexamfetamine Dimesylate Capsules
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 9 month long term stability station (25¿C, 60%RH).
- Products
-
- Lisdexamfetamine Dimesylate Capsules
- Where it was sold
-
Recalled units were distributed to 17 distributors who may have further distributed the product nationwide.
Nationwide
- Units affected
- 5,448 bottles
- About this recall
- Lisdexamfetamine Dimesylate Capsules, 60 mg, CII, 100-count bottles, Rx only, Manufactured by: OHM Laboratories, New Brunswick, NJ 08901, Distributed by: Sun Pharmaceuticals, Inc., Cranbury, NJ 08512, NDC 57664-051-88